E-DRUG Archives (by thread)

  • E-DRUG: Norgestrel and combined contraceptive pills (cont'd), Gaut Gadeholt
  • E-DRUG: GMP and how to get the reliable suppliers (cont'd), Gaut Gadeholt
  • E-DRUG: Ketotifen (cont'd), Gaut Gadeholt
  • E-DRUG: Ketotifen, Leo Offerhaus
  • E-DRUG: King's Fund Breakfast Seminar (London, UK), David Gilbert
  • E-DRUG: U.S. FDA says generic drugs as good as brand names, srahmad
  • E-DRUG: Norgestrel and combined contraceptive pills (contd), Kirsten Myhr
  • E-DRUG: FTAA - Health Care and IP, James Love
  • E-DRUG: Sedation of children pre-op, Tim Dodd
  • E-DRUG: Prescrire International at lower price, international
  • E-DRUG: Mail-order drug delivery (contd), Kirsten Myhr
  • E-DRUG: Sedation of children pre-op (cont'd), Joel Lexchin
  • E-DRUG: Nomination Director General WHO (cont'd), TSUTANI Kiichiro
  • E-DRUG: Gender differences in drug utilization, Alec Walker
  • E-DRUG: FTAA - Health Care and IP (contd), James Love
  • E-DRUG: Diluent of vaccines (contd), FBA
  • E-DRUG: Conference announcement, Mullerova Hana
  • E-DRUG: WHO-EB Resolution on Revised Drug Strategy, Hai
  • E-DRUG: Generic drugs versus brand names, Mark Campbell
  • E-DRUG: Mail-order drug delivery (cont'd), Joel Lexchin
  • E-DRUG: Gender differences in drug utilization (cont'd), Joel Lexchin
  • E-DRUG: Norgestrel in contraceptive pills (cont'd), Marcel Reyners
  • E-DRUG: Antidiarrhoeal Ercefuryll, Truls Eriksen
  • E-DRUG: U.S. FDA issues Warning on Astemizole, srahmad
  • E-DRUG: RFI: Drug Companies and Social Action Programs, Sheila J. Madhani
  • E-DRUG: Ethics on research in developing countries, procaare
  • E-DRUG: Use of hyoscine to promote the first stage of labour, Moses Chisale
  • E-DRUG: Antidiarrhoeal Ercefuryll (cont'd), Tim Dodd
  • E-DRUG: Ethics of AIDS Drug Trials, srahmad
  • E-DRUG: U.S. FDA Warning on Pain killer, srahmad
  • E-DRUG: Bolar Roche provision?, Bada Pharasi
  • E-DRUG: Bolar Roche provision (cont'd), Joel Lexchin
  • E-DRUG: Bolar Roche exemption (cont'd), Michael Davis
  • E-DRUG: Isomers and omeprazole, Kirsten Myhr
  • E-DRUG: Changes at National Library of Medicine, Joan D. Levin
  • E-DRUG: Antidiarrhoeal Ercefuryl (cont'd), Jerome Sclafer
  • E-DRUG: Changes at National Library of Medicine (cont'd), Joan D. Levin
  • E-DRUG: Use of drugs in sports, Nyaroo Eric Achoki
  • E-DRUG: South African Health Review 1997, Chapter 10: Drug Policy, Halima Rooplall
  • E-DRUG: Isomers and omeprazole (cont'd), Randy Trinkle
  • E-DRUG: Safety of Fexofenadine ( Allegra), Carmen Cano
  • E-DRUG: Safety of Fexofenadine (cont'd), Joel Lexchin
  • E-DRUG: Many NSAID users who bleed don't know when to stop, srahmad
  • E-DRUG: Course "Pharmacoepidemiology: The Cuban Model", CDF Cuba
  • E-DRUG: Use of drugs in sports (cont'd), Kirsten Myhr
  • E-DRUG: Many NSAID users who bleed ...... (cont'd), Alec Walker
  • E-DRUG: Inappropriate combinations with corticosteroids (cont'd), Yupp Javroongrit
  • E-DRUG: Use of Oxygen in the Home Environment, Tony Odendaal
  • E-DRUG: Insulin stability (cont'd), Kirsten Myhr
  • E-DRUG: Vacancy, HLSP Ltd
  • E-DRUG: HIV trials in developing countries, srahmad
  • E-DRUG: POPP PKPD Draft discussion paper, David Addison
  • E-DRUG: HIV trials in developing countries (cont'd), David Gilbert
  • E-DRUG: WHO Plan To Halt Antibiotic Resistance, srahmad
  • E-DRUG: National Library of Medicine (cont'd), Joan D. Levin
  • E-DRUG: Use of Isotretinoin in pregnancy, Jerome Sclafer
  • E-DRUG: Dipyrone, F. Cankat Tulunay
  • E-DRUG: Mefloquine price wars in South Africa, Andrew Jamieson
  • E-DRUG: Dipyrone (cont'd), Leo Offerhaus
  • E-DRUG: International Society for Pharmacoepidemiology, Alec Walker
  • E-DRUG: new TB discussion list, Ian Smith
  • E-DRUG: Consumers' Guide to Safe, Cost-effective Medicines, Elaine Cosser
  • E-DRUG: U.S. FDA on Anti-Acne Drug, srahmad
  • E-DRUG: Consumers' Guide to Safe, Cost-effective Medicines (cont'd), Joel Lexchin
  • E-DRUG: Consumers' Guide to Safe, Cost-effective Medicin (cont'd), Dennis Ross-Degnan
  • E-DRUG: Consumers' Guide to Safe, Cost-effective Meds, ra
  • E-DRUG: Terfenadine withdrawn from the U.S. market, srahmad

  • Mail converted by MHonArc 2.4.9